IL148405A0 - Antibody dye cojugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries - Google Patents

Antibody dye cojugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries

Info

Publication number
IL148405A0
IL148405A0 IL14840500A IL14840500A IL148405A0 IL 148405 A0 IL148405 A0 IL 148405A0 IL 14840500 A IL14840500 A IL 14840500A IL 14840500 A IL14840500 A IL 14840500A IL 148405 A0 IL148405 A0 IL 148405A0
Authority
IL
Israel
Prior art keywords
cojugates
intraoperatively
angiogenesis
binding
order
Prior art date
Application number
IL14840500A
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL148405(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL148405A0 publication Critical patent/IL148405A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL14840500A 1999-09-24 2000-08-19 Antibody dye cojugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries IL148405A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (en) 1999-09-24 1999-09-24 Antibody-dye conjugates against target structures of angiogenesis for intraoperative tumor border imaging
PCT/EP2000/008121 WO2001023005A1 (en) 1999-09-24 2000-08-19 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries

Publications (1)

Publication Number Publication Date
IL148405A0 true IL148405A0 (en) 2002-09-12

Family

ID=7924318

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14840500A IL148405A0 (en) 1999-09-24 2000-08-19 Antibody dye cojugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries
IL148405A IL148405A (en) 1999-09-24 2002-02-27 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periphery

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148405A IL148405A (en) 1999-09-24 2002-02-27 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor periphery

Country Status (23)

Country Link
EP (2) EP1214099A1 (en)
JP (1) JP2003510294A (en)
KR (2) KR100832937B1 (en)
CN (1) CN1269530C (en)
AU (1) AU779026B2 (en)
BG (1) BG65682B1 (en)
BR (1) BR0014192A (en)
CA (1) CA2385593A1 (en)
CZ (1) CZ2002991A3 (en)
DE (1) DE19947559A1 (en)
EE (1) EE05176B1 (en)
HK (1) HK1050491A1 (en)
HU (1) HUP0202625A2 (en)
IL (2) IL148405A0 (en)
MX (1) MXPA02002639A (en)
NO (1) NO20021441L (en)
NZ (1) NZ517944A (en)
RO (1) RO121598B1 (en)
RU (1) RU2002109237A (en)
SK (1) SK3972002A3 (en)
WO (1) WO2001023005A1 (en)
YU (1) YU20702A (en)
ZA (1) ZA200203225B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524018A (en) 2000-02-24 2003-08-12 アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ Antibodies specific for the ED-B domain of fibronectin, complexes containing said antibodies, and uses thereof for detecting and treating angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (en) * 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie USE OF ANTIBODIES TO TUMOR ASSOCIATED ANTIGEN
NO20034351D0 (en) * 2003-09-29 2003-09-29 Amersham Health As Optical imaging of endometriosis
ATE374367T1 (en) * 2004-07-22 2007-10-15 Bayer Schering Pharma Ag USE OF CYANINE DYES FOR DIAGNOSING DISEASES ASSOCIATED WITH ANGIOGENESIS
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
US20120041305A1 (en) * 2009-04-21 2012-02-16 The University Of Utah Research Foundation Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
WO2018026965A1 (en) * 2016-08-02 2018-02-08 Isi Life Sciences, Inc. Compositions and methods for detecting cancer cells in a tissue sample

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
WO1996001653A1 (en) * 1994-07-11 1996-01-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
KR20070087232A (en) 2007-08-27
HK1050491A1 (en) 2003-06-27
NO20021441D0 (en) 2002-03-22
WO2001023005A1 (en) 2001-04-05
DE19947559A1 (en) 2001-04-19
CN1269530C (en) 2006-08-16
CA2385593A1 (en) 2001-04-05
NO20021441L (en) 2002-05-15
PL354027A1 (en) 2003-12-15
EE05176B1 (en) 2009-06-15
HUP0202625A2 (en) 2002-12-28
EE200200152A (en) 2003-04-15
RU2002109237A (en) 2003-11-27
KR100832937B1 (en) 2008-05-27
EP1532988A3 (en) 2008-09-17
EP1532988A2 (en) 2005-05-25
BG106528A (en) 2002-12-29
BR0014192A (en) 2002-05-21
BG65682B1 (en) 2009-06-30
IL148405A (en) 2009-06-15
CN1376074A (en) 2002-10-23
YU20702A (en) 2005-06-10
MXPA02002639A (en) 2002-07-30
ZA200203225B (en) 2003-07-23
CZ2002991A3 (en) 2002-06-12
AU779026B2 (en) 2005-01-06
JP2003510294A (en) 2003-03-18
RO121598B1 (en) 2007-12-28
SK3972002A3 (en) 2002-09-10
AU6702600A (en) 2001-04-30
NZ517944A (en) 2004-06-25
KR20020039349A (en) 2002-05-25
EP1214099A1 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
EP1187633A4 (en) Use of anti-vegf antibody to enhance radiation in cancer therapy
AU3041100A (en) Binding of antibody fragments to solid supports
NO20016114L (en) Preparations and Methods to Increase Cholesterol Elevation and Raise HDL Using ATP Binding Cartridge Carrier Protein ABC1
AP2000001983A0 (en) Antibodies to cd23 derivatives thereof and their therapeutic uses
IS2468B (en) Methods and Intermediates for the Preparation of Cancer Compounds
AU2605501A (en) Inducing cellular immune responses to prostate cancer antigens using peptide andnucleic acid compositions
EP1224274A4 (en) Tumor necrosis factor related receptor, tr6
HK1038512A1 (en) Methods of inducing cancer cell death and tumor regression
NO20011674L (en) Strapless toe lock binding for snowboards
IL148405A0 (en) Antibody dye cojugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries
IS5502A (en) Conjugated compounds useful in the treatment of prostate cancer
NO20023971D0 (en) Hormone therapy for breast cancer
DE60031784D1 (en) IMPROVED HIGH TEMPERATURE SUPER PLATE COATED ELEMENTS
EP1208232A4 (en) Markers for prostate cancer
EP1191940A4 (en) Tumor necrosis factor receptor 5
EG22346A (en) Process for the preparation of conjugates useful in the treatment of prostate cancer
NO20013607L (en) Ski binding for telemark skiing
EP1171579A4 (en) Human tumor necrosis factor receptor tr9
EP1210370A4 (en) Human tumor necrosis factor receptor tr16
NZ523207A (en) Antibodies that bind to tumor gene sequences
TW410784U (en) Improved structure of hydraulic brake
NZ523209A (en) Antibodies that bind to tumor gene sequences
NO990561L (en) Procedure for the preparation of skis
GB9908918D0 (en) Improvements relating to heating elements
IL135325A0 (en) Composition for treatment of malignant tumor